Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-02
1997-05-06
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549461, C07D30791, A61K 3134
Patent
active
056272065
ABSTRACT:
A tricyclic compound is described as well as pharmaceutical compositions of same, which is useful as an inhibitor of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) for the treatment of multiple sclerosis or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes.
REFERENCES:
J. Clin. Invest., vol. 94, 1994, Galis et al., pp. 2494-2503.
Proc. Nat'l. Acad. Sci. USA, vol. 88, 1991, Henney et al., pp. 8154-8158.
Clin. Sci., vol. 81, 1991, Vine and Powell, pp. 233-239.
Am. J. Cardiol., vol. 72, 1993, Lee et al., pp. 672-676.
Clin Res., vol. 41, 1993, Reddy et al., p. 660A.
Clin. Res., vol. 41, 1993, Tyagi et al., p. 681A.
Can. J. Cardiol., vol. 10, 1994, Armstrong et al., pp. 214-220.
Am. J. Physiol., vol. 263, 1992, Sabbah et al., pp. H266-H270.
Circulation Research, vol. 75, 1994, Bendeck et al., pp. 539-545.
Circulation Research, vol. 75, 1994, Pauly et al., pp. 41-54.
J. Periodontal Res., vol. 16, 1981. Uitto et al., pp. 417-424.
J. Periodontal Res., vol. 22, 1987, Overall et al., pp. 81-88.
Arch. Opthalmol., vol. 81, 1969, Brown et al., pp. 370-373.
Invest. Opththanol., vol. 30, 1989, Burns et al., pp. 1569-1575.
Cancer Res., vol. 53, 1993, Davies et al., pp. 2087-2091.
Cancer Res., vol. 52, 1992, Melchiori et al., pp. 2353-2356.
Cancer Res., vol. 52, 1992, DeClerck et al., pp. 701-708.
J. Biol. Chem., vol. 268, No. 19, 1993, Strongin et al., pp. 14033-14039.
Cancer Res., vol. 53, 1993, Monsky et al., pp. 3159-3164.
Journal of the National Cancer Institute, vol. 87, No. 4, 1995, Taraboletti et al., pp. 293-298.
Oncology Research, vol. 6, 1994, Benelli et al., pp. 251-257.
Arthritis and Rheumatism, vol. 35, No. 1, 1992, Walakovits et al., pp. 35-42.
J. Rheumatol. vol. 20, No. 4, 1993, Zafarullah et al., pp. 693-697.
Agents Actions, vol. 37, No. 1/2, 1992, Andrews et al., pp. 147-154.
Biochem. Biophys. Res. Commun., vol. 201, No. 1, 1994, Ellis et al., pp. 94-101.
J. Clin. Invest., vol. 94, 1994, Gijbels et al., pp. 2177-2182.
Scientific American, vol. 269, No. 3, 1993, Steinman, pp. 107-114.
Cell-Immunol., vol. 82, No. 1, 1983, Paterson, pp. 55-74.
Annals of the New York Academy of Sciences, eds Scheinberg and Raine, vol. 436, 1984, Bornstein et al., pp. 366-372.
Bio/technology, vol. 13, 1995, Steinman and Conlon, pp. 118-120.
Immunol-Ser., vol. 59, 1993, Steinman et al., pp. 253-260.
The Blood Brain Barrier in Health and Disease, edited by Suckling et al., 1986, Lam, pp. 158-164.
Brain, vol. III, 1988, Miller et al., pp. 927-939.
Neurology, vol. 41, 1991, Barkhof et al., pp. 1219-1222.
Biochemical Pharmacology, vol. 47, No. 10, 1994, Moor et al., pp. 1717-1724.
Nature, vol. 356, 1992, Yednock et al., p. 63-66.
Brain Research, vol. 576, 1992, Rosenberg et al., pp. 203-207.
J. Cell Biology, vol. 125, No. 5, 1994, Romanic and Madri, pp. 1165-1178.
TiPS Reviews, vol. 14, 1993, Dijkstra et al., pp. 124-129.
Annals of Neurology, vol. 36, 1994, Wekerle et al., pp. S47-S53.
J. Neurochem., vol. 50, No. 3, 1988, Chantry et al., pp. 688-694.
Biochemical and Biophysical Research Communications, vol. 192, No. 3, 1993, Proost et al., pp. 1175-1181.
Journal of Cellular Physiology, vol. 157, 1993, Weeks et al., pp. 644-649.
Biochemica et Biophysica Acta, vol. 1176, 1993, Montgomery et al., pp. 265-268.
Current Opinion in Neurology and Neurosurgery, vol. 5, 1992, Lublin, pp. 182-187.
Journal of Neuroimmunology, vol. 21, 1989, Sternberger et al., pp. 241-248.
Nature, vol. 370, 1994, Mohler et al., pp. 218-220.
Nature, vol. 370, 1994, Gearing et al., pp. 555-557.
The Journal of Immunology, vol. 154, 1995, Verbeek et al., pp. 5876-5884.
Cellular Immunology, vol. 81, 1983, McKenna et al., pp. 391-402.
Cellular Immunology, vol. 112, 1988, Bitar and Whitacre, pp. 364-370.
Journal of Neuroimmunology, vol. 34, 1991, Kuroda and Shimamoto, pp. 159-164.
The Journal of Immunology, vol. 147, No. 7, 1991, Whitacre et al., pp. 2155-2163.
Journal of Neuroimmunology, vol. 38, 1992, O'Neill et al., pp. 53-62.
Journal of Neuroimmunology, vol. 39, 1992, Whitacre et al., pp. 175-182.
Cellular and Molecular Immunology, ed. Saunders, 1991, Abbas et al., pp. 364-369.
Nature, vol. 370, 1994, McGeehan et al., pp. 558-561.
Hupe Donald
Johnson Linda Lea
Ye Qi-Zhuang
Cross Laura R.
Richter Johann
Tinney Francis J.
Warner-Lambert & Company
LandOfFree
Tricyclic inhibitor of matrix metalloproteinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic inhibitor of matrix metalloproteinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic inhibitor of matrix metalloproteinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2133037